• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亚洲国家的口腔黏膜下纤维性变。

Oral submucous fibrosis in Asian countries.

机构信息

Xiangya Stomatological Hospital, Central South University, Changsha, China.

Xiangya School of Stomatology, Central South University, Changsha, China.

出版信息

J Oral Pathol Med. 2020 Apr;49(4):294-304. doi: 10.1111/jop.12924. Epub 2019 Jul 16.

DOI:10.1111/jop.12924
PMID:31310693
Abstract

Oral submucous fibrosis (OSF) is a chronic, insidious, and progressive oral mucosal disease that affects entire oral cavity and sometimes pharynx. This oral potentially malignant disorder has a high rate of malignant transformation (7%-30%) to oral squamous cell carcinoma (OSCC), posing global problems for public health. Due to enormous efforts dedicated to this disease in the past decades, there have been significant advances in identification of its etiology and pathogenesis as well as development of corresponding therapeutic approaches, in spite of several challenges. This study reviewed the existing literature concerning OSF in Asian countries, encompassing its etiology, histopathology, pathogenesis, clinical manifestations, diagnosis and differential diagnosis, and treatments. For improving treatment of OSF, the multifactorial etiology analysis, incorporation of effective molecular pathways, cytokines and cells for mechanism illustration, and integration of multidisciplinary modalities were also expounded to guide future research and clinical practice.

摘要

口腔黏膜下纤维性变(OSF)是一种慢性、隐匿性、进行性的口腔黏膜疾病,影响整个口腔,有时还会影响咽部。这种口腔潜在的恶性疾病具有很高的恶性转化(7%-30%)为口腔鳞状细胞癌(OSCC)的风险,对全球公共健康构成了问题。尽管存在一些挑战,但由于过去几十年来对这种疾病的巨大努力,在确定其病因和发病机制以及开发相应的治疗方法方面取得了重大进展。本研究综述了亚洲国家有关 OSF 的现有文献,包括其病因、组织病理学、发病机制、临床表现、诊断和鉴别诊断以及治疗。为了改善 OSF 的治疗效果,还阐述了多因素病因分析、纳入有效的分子途径、细胞因子和细胞以阐明机制,以及整合多学科模式,以指导未来的研究和临床实践。

相似文献

1
Oral submucous fibrosis in Asian countries.亚洲国家的口腔黏膜下纤维性变。
J Oral Pathol Med. 2020 Apr;49(4):294-304. doi: 10.1111/jop.12924. Epub 2019 Jul 16.
2
The role of epithelial-mesenchymal transition in oral squamous cell carcinoma and oral submucous fibrosis.上皮-间质转化在口腔鳞状细胞癌和口腔黏膜下纤维化中的作用
Clin Chim Acta. 2007 Aug;383(1-2):51-6. doi: 10.1016/j.cca.2007.04.014. Epub 2007 Apr 29.
3
Oral Submucous Fibrosis: Etiological Mechanism, Malignant Transformation, Therapeutic Approaches and Targets.口腔黏膜下纤维性变:病因机制、恶性转化、治疗方法和靶点。
Int J Mol Sci. 2023 Mar 5;24(5):4992. doi: 10.3390/ijms24054992.
4
High risk of malignant transformation of oral submucous fibrosis in Pakistani females: A potential national disaster.巴基斯坦女性口腔黏膜下纤维化的恶性转化风险高:一场潜在的国家灾难。
J Pak Med Assoc. 2016 Nov;66(11):1362-1366.
5
DNA content abnormality in oral submucous fibrosis concomitant leukoplakia: A preliminary evaluation of the diagnostic and clinical implications.口腔黏膜下纤维性变伴发白斑中 DNA 含量异常:对诊断和临床意义的初步评估。
Diagn Cytopathol. 2020 Nov;48(11):1111-1114. doi: 10.1002/dc.24469. Epub 2020 May 20.
6
Oral submucous fibrosis: a contemporary narrative review with a proposed inter-professional approach for an early diagnosis and clinical management.口腔黏膜下纤维性变:一种当代叙述性综述,提出了一种多专业协作的方法,以实现早期诊断和临床管理。
J Otolaryngol Head Neck Surg. 2020 Jan 8;49(1):3. doi: 10.1186/s40463-020-0399-7.
7
MALDI imaging reveals NCOA7 as a potential biomarker in oral squamous cell carcinoma arising from oral submucous fibrosis.基质辅助激光解吸电离成像显示,NCOA7是口腔黏膜下纤维化引发的口腔鳞状细胞癌中的一种潜在生物标志物。
Oncotarget. 2016 Sep 13;7(37):59987-60004. doi: 10.18632/oncotarget.11046.
8
Areca nut in pathogenesis of oral submucous fibrosis: revisited.槟榔在口腔黏膜下纤维化发病机制中的作用:再探讨
Oral Maxillofac Surg. 2011 Mar;15(1):1-9. doi: 10.1007/s10006-010-0219-8.
9
Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis.p53和p63在口腔鳞状细胞癌、口腔白斑及口腔黏膜下纤维化中的免疫组化检测
J Investig Clin Dent. 2014 Aug;5(3):214-9. doi: 10.1111/jicd.12038. Epub 2013 Jun 18.
10
Oral submucous fibrosis: a clinicopathologic review of 205 cases in Indians.口腔黏膜下纤维化:205例印度患者的临床病理回顾
Oral Maxillofac Surg. 2011 Mar;15(1):15-9. doi: 10.1007/s10006-010-0225-x.

引用本文的文献

1
Predictive value of quantitative DNA analysis in the carcinogenesis of oral submucous fibrosis.定量DNA分析在口腔黏膜下纤维化癌变中的预测价值
Am J Transl Res. 2025 Jun 15;17(6):4278-4287. doi: 10.62347/HMPQ6800. eCollection 2025.
2
Diagnosing malignant transformation potential in oral submucous fibrosis with leukoplakia: an approach utilizing deoxyribonucleic acid image cytometry.利用脱氧核糖核酸图像细胞术诊断伴有白斑的口腔黏膜下纤维化的恶性转化潜能:一种方法
Sci Rep. 2025 Jul 1;15(1):22085. doi: 10.1038/s41598-025-05870-9.
3
Diagnostic Accuracy of DNA Ploidy for Oral Potentially Malignant Disorders: A Systematic Review and Meta Analysis.
DNA倍体对口腔潜在恶性疾病的诊断准确性:一项系统评价和Meta分析
Asian Pac J Cancer Prev. 2025 Apr 1;26(4):1155-1164. doi: 10.31557/APJCP.2025.26.4.1155.
4
NCK1 antisense RNA 1 (NCK1-AS1) exerts pro-fibrosis property in oral mucosa through modulation of miR-137/NCK1 axis.NCK1反义RNA 1(NCK1-AS1)通过调控miR-137/NCK1轴在口腔黏膜中发挥促纤维化作用。
J Dent Sci. 2025 Jan;20(1):632-638. doi: 10.1016/j.jds.2024.11.003. Epub 2024 Nov 14.
5
Pre-assembled nanospheres in mucoadhesive microneedle patch for sustained release of triamcinolone in the treatment of oral submucous fibrosis.用于曲安奈德持续释放以治疗口腔黏膜下纤维化的黏膜粘附微针贴剂中的预组装纳米球。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024 Aug 28;49(8):1245-1260. doi: 10.11817/j.issn.1672-7347.2024.240226.
6
Emerging functions of lycopene in the management of digestive premalignant lesions.番茄红素在消化系统癌前病变管理中的新功能
Front Pharmacol. 2024 Oct 17;15:1478170. doi: 10.3389/fphar.2024.1478170. eCollection 2024.
7
Effect of Jiedu Huayu decoction on oral mucosal Axin and β-catenin expression in oral submucosal fibrosis model rats.解毒化瘀汤对口腔黏膜下纤维化模型大鼠口腔黏膜 Axin 和β-连环蛋白表达的影响。
J Tradit Chin Med. 2024 Aug;44(4):688-693. doi: 10.19852/j.cnki.jtcm.20240617.001.
8
A scientometric study on research trends and characteristics of oral submucous fibrosis.一项关于口腔黏膜下纤维化研究趋势与特征的科学计量学研究。
J Dent Sci. 2024 Jul;19(3):1834-1839. doi: 10.1016/j.jds.2024.05.006. Epub 2024 May 18.
9
Adiponectin inhibits ROS/NLRP3 inflammatory pathway through FOXO3A to ameliorate oral submucosal fibrosis.脂联素通过 FOXO3A 抑制 ROS/NLRP3 炎症通路改善口腔黏膜下纤维化。
Odontology. 2024 Jul;112(3):811-825. doi: 10.1007/s10266-023-00891-0. Epub 2024 Jan 13.
10
Mechanisms and markers of malignant transformation of oral submucous fibrosis.口腔黏膜下纤维化恶性转化的机制与标志物
Heliyon. 2023 Dec 7;10(1):e23314. doi: 10.1016/j.heliyon.2023.e23314. eCollection 2024 Jan 15.